Rain, rain, go away... Yes, the deluge continues. The skies have opened once again over the Pharmalot corporate campus this morning, which complicates the process of getting the short people off to their various school houses. Nonetheless, we will persevere. To do so, we are quaffing that mandatory cup of stimulation and, of course, invite you to join us. And why not? A cup - or more - a day can keep the sleepies away. Meanwhile, here are some tidbits. Dig in and have a good one...
P&G Sees Emerging Markets And Teva Deal Fueling Sales (Associated Press)
Ranbaxy Aims To Sell Generic Lipitor On Schedule (Bloomberg News)
Pfizer Arthritis Drug Shows Mixed Results (Reuters)
Indonesian Court Overturns Antitrust Ruling Against Pfizer (Dow Jones)
J&J And Bayer Bloodthinner Faces FDA Panel Today (Associated Press)
Dendreon Readies Cost-Cutting Plan (The Street)
FDA Warns Of New Infections With TNF Blockers (MedPage Today)
Fewer Medicare Part D Enrollees Reach Donut Hole (Associated Press)
Shire CEO: Pharma Must 'Wake Up' To Price Reality (Philadelphia Business Journal)
ICON Shrugs Off CEO Departure (Outsourcing Pharma)
EDITOR’S NOTE: Please check this post for updates throughout the morning
steaming coffee thx to dleggett on flickr